PI, protease inhibitor Table 2: * For continuous variables, treatment effect and p-values are from repeated measures analysis for primary and secondary endpoints with interim measures (hepatic fat absolute change, ALT, VAT, SAT, BMI, and glucose) and from between-group comparison of change at 12 months by Students t-test for other variables
In the PERSONS cohort, analysis of 569 patients with biopsy-proven MASH showed that statin use was inversely associated with MASH (OR: 0.55
Attia received his medical degree from the Stanford University School of Medicine and trained for five years at the Johns Hopkins Hospital in general surgery, where he was the recipient of several prestigious awards, including resident of the year
Agers H, Jensen LB, Elbrnd B, et al
2013 FDA safety communication reviewing data on pancreatic cancer risk
However, another major culprit is insurance companies